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Commentary A syndrome is defined by Merriam-Webster dictionary as a "group of sign and symptoms that occur together and characterize a particular abnormality or condition. " This is exactly what Harvey et al. attempted to define with the syndrome of "bottom-of-sulcus dysplasia. " They reported that seizures associated with bottom-of-sulcus dysplasia (BOSD) usually begin in early childhood, are predominantly nocturnal with frontal lobe semiology, and patients have relatively intact cognitive function. Interictal EEG shows prominent spiking. Resection of the dysplasia was highly successful in eliminating seizures.
Despite the study being a retrospective review, the description of a syndrome is very powerful, as any combination of symptoms and signs will help the clinician recognize a similar group of patients. This assists in treating the syndrome with whatever has worked in earlier patients with similar constellations of signs and symptoms. In the appropriate clinical setting, a clinician may suspect the syndrome even though the final imaging evidence or pathologic confirmation of the syndrome may be lacking.
Another strength of this study stems from the pathological confirmation of the diagnosis. All patients had pathological confirmation of focal cortical dysplasia type IIB after surgery. The authors retrospectively looked at the MRI characteristics and found cortical thickening and blurring of the grey-white matter junction in all patients, FLAIR hyperintensities in 30 of the 32 patients and a transmantle sign in 20. However, initial routine neuroradiologic review missed 22% of the abnormalities, which is consistent with previously reported series (1). This again stresses the importance of diagnosing a clinical syndrome to carefully search for an imaging abnormality if the appropriate sign and syndrome constellation occur. In MRI negative cases, FTG-PET imaging helped to identify five of remaining seven MRI negative cases. If MRI fails to show focal cortical dysplasia, FDG-PET can be valuable to identify the abnormality (2) .
Seizure semiology localized to the frontal and perisylvian areas with "explosive" seizure onset, nocturnal predominance, hypermotor features, or asymmetric tonic features has been previously described as typical for seizure onset in the frontal lobes (3, 4) . Twenty-nine of the 32 patients with BOSD were localized in the frontal lobes or in the perisylvian region. In OBJECTIVE: To determine clinical and EEG features that might help identify patients with epilepsy harboring small, intrinsically epileptogenic, surgically treatable, bottom-of-sulcus dysplasias (BOSDs). METHODS: Retrospective review of clinical records, EEG, MRI, and histopathology in 32 patients with drug-resistant epilepsy and MRI-positive (72% 3.0 tesla), pathologically proven (type 2B cortical dysplasia) BOSDs operated at our centers during 2005-2013. RESULTS: Localization of BOSDs was frontal in 19, insula in 5, parietal in 5, and temporal in 3, on the convexity or interhemispheric surfaces. BOSDs were missed on initial MRI at our centers in 22% of patients. Patients presented with focal seizures during infancy in 9, preschool years in 15, and school years in 8 (median age 5 years). Seizures were stereotyped, predominantly nocturnal, and typically nonconvulsive, with semiology referable to the fronto-central or perisylvian regions. Seizures occurred at high frequency during active periods, but often went into prolonged remission with carbamazepine or phenytoin. Intellect was normal or borderline, except in patients with seizure onset during infancy. Scalp EEG frequently revealed localized interictal epileptiform discharges and ictal rhythms. Patients underwent lesionectomy (median age 14 years) guided by electrocorticography and MRI, with prior intracranial EEG monitoring in only one patient. Twenty-eight patients (88%) became seizure-free, and 20 discontinued antiepileptic medication (median follow-up 4.1 years). CONCLUSIONS: In patients with cryptogenic focal epilepsy, this clinical presentation and course should prompt review of or repeat MRI, looking for a BOSD in the frontal, parietal, or insula cortex. If a BOSD is identified, the patient might be considered for single-stage lesionectomy.
Bottom-of-Sulcus Dysplasia as an Epileptic Syndrome: The Power of Clinical Correlation
only three patients was the dysplasia located in the temporal lobes. The question arises whether BOSDs have a distinct predilection for those regions or were dysplasias located in other areas not identified? Type II focal cortical dysplasia have been reported more frequently within the parietal and frontal lobes as compared to the temporal lobes by other authors (1, 5) . Focal cortical dysplasia type I (no balloon cells or dysmorphic cells) and focal cortical dysplasia type III (in conjunction with other lesions, such as mesial temporal sclerosis) seem to be more common in the temporal areas (5, 6) . Focal cortical dysplasias-whether at the bottom or top of the sulcusprobably present a continuum from very small abnormalities to large multilobar abnormalities. Other disorders of neuronal migration, such as perisylvian syndrome or polymicrogyria, also have a predilection for the frontal-parietal areas (7) . This may indicate that the disturbance of the neuronal maturation probably occurs at a similar point during development.
Harvey et al. found a strong predilection for the right hemisphere in more than 60% of patients. It is unclear whether right hemisphere predominance is a generally associated with BOSD or whether this is just a reflection that epilepsy surgery is more easily entertained in the right hemisphere as there is less risk of a language deficit. The syndrome of bottom-ofsulcus dysplasia also raises the question whether there is a syndrome of the top-of-gyrus dysplasia or does bottom-of-sulcus just mean it is a small dysplasia and, henceforth, the good surgical outcome. The question remains unanswered.
In the Harvey et al. study, patients had normal development of cognitive function and later on developed more specific cognitive deficits. This again raises the question of the true cause of cognitive impairment in epilepsy. Is it the underlying pathology, the occurrence of seizures, arrested cognitive development, or possibly the result of antiepileptic medications? So far, there is no answer to these questions, but this study adds to the evidence that cognitive deficits are progressive (8) . Interventions that avoid the eventual cognitive decline are urgently needed (9) .
The authors report a seizure-free outcome of 88%, which is excellent for focal frontal lobe epilepsy and superior to the average outcome of 55% reported in a meta-analysis of focal cortical dysplasia (10) . This meta-analysis also reported that focal cortical dysplasia type II does significantly better than type I, and patients with temporal locations do better than others (10) .
The extent of the resections discussed in Harvey et al. was quite variable. Most had the cortical component of the dysplasia resected. Only 60% also had the area of the transmantle sign resected. Three patients became seizure free after a second operation. The patients who were not seizure free seemed to have residual dysplastic tissue left on follow-up imaging. The questions remains, if a BOSD is identified on imaging, how much needs to be resected, and does the area of the transmantle sign need to be included? A previous study reported that resection of the transmantle sign is not necessary (11) . Possibly, some more detailed intracranial electrophysiology could answer the question and, in addition, may have helped avoid the motor deficits reported in two patients by thorough functional mapping.
In summary, this study shows that careful clinical evaluation of a clinical syndrome can be extremely helpful and that all aspects of a syndrome-not isolated imaging results alone-need to be considered when evaluating patients. Attention to detail with all clinical signs and symptoms, in addition to diagnostic tests, can frequently give the answer so that patients can benefit from the appropriate intervention, in this case, the resection of the dysplasia.
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